Sheryl LaCoursiere, PhD, RN-BC
Cynthia Patton,  RN, MSN                           

 

      HYPERTENSION

Blood flowing through blood vessels

 

 

HYPERTENSION PRESENTATION

 

JNC GUIDELINES

 The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7)

 On the JNC home page, there are a number of important resources for clinicians as well as patient resources, including:

 

EVALUATION OF HYPERTENSION

Hypertension is evaluated by a four-step process:

The patient is then assessed for:

 

 

                                                                                                                               Evaluation of Hypertension

                                                                                                                                                                               From the JNC Reference Card

 

TREATMENT OF HYPERTENSION

                                                                                                                            Treatment of Hypertension             

                                                                                                                                                                                            From the JNC Reference Card

 

    

 LIFESTYLE MODIFICATIONS, and the DIETARY APPROACHES TO STOP HYPERTENSION (DASH) DIET

 

Lifestyle Modification Recommendations

                                                                                    From the JNC Reference Card

 

 

     MEDICATIONS

  1. Thiazide Diuretics (THIAZ)

  2. Beta-blockers (BB)

  3. Angiotensin Converting Enzyme Inhibitors (ACEI)

  4. Angiotensin Release Blockers (ARB)

  5. Aldosterone antagonists (ALDO ANT)

  6. Calcium Channel blockers (CCB)

Examples of medications for each class are shown below

Oral Antihypertensive Medications

                                                                                                                                                                                    From the JNC Complete Report, pp. 27-28

 

  1. Heart failure

  2. Post myocardial infarction

  3. High cardiovascular disease (CVD) risk

  4. Diabetes

  5. Chronic kidney disease; and

  6. Recurrent stroke prevention

Compelling Indications for Individual Drug Classes

                                                                                 From the JNC Reference Card

 

 


Modified April 18, 2007
Questions?